A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development.
Antimalarial drugs chloroquine and hydroxychloroquine could make tumour cells more sensitive to cancer treatment.
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The findings, published in Nature Communications, may improve current strategies to improve blood flow in ischemic tissue, such as that found in atherosclerosis and peripheral vascular disease associated with diabetes.
The same bacteria present in primary tumors of patients with colorectal cancer are also present in liver metastases, a new study finds.
UVA is developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options. The tool could help patients with other forms of cancer as well.
In a study published in EPJ D, Eugene Surdutovich from Oakland University, Rochester, Michigan, USA and colleagues have examined the possibility of observing the multi-fragmentation of small droplets due to shock waves initiated by ions that passed through them. The discovery of ion-induced shock waves will significantly affect our understanding of how radiation damage occurs in biomolecules due to ions.
Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension.
Tiny robots could be developed to diagnose illness and deliver treatments in hard-to-reach parts of the human body.
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, making them easier to kill.
Risk for aging-related diseases such as heart disease and diabetes was significantly higher among thyroid cancer survivors in Utah than it was among age-matched, cancer-free individuals, with those diagnosed before age 40 having the highest risk for some of the diseases.